A team of physicists at the Institut Lumière Matière (CNRS/Université Claude Bernard Lyon 1), in collaboration with the Cancer Research Center of Lyon (CNRS/INSERM/ Université Claude Bernard Lyon 1/Centre Léon Bérard/Hospices civils de Lyon), has demonstrated the potential, for oncology, of an imaging technique based only on the physical properties of tumors. It can differentiate populations of malignant cells and monitor how effective an anticancer treatment is. These results, published in Physical Review Letters on January 8, 2019, should help in the design of new therapeutic molecules and in the personalization of treatments.
Despite a good understanding of the biology of cancer, 90% of experimental drugs fail during clinical trials. It is also increasingly suspected that the mechanical properties of tumors influence disease progression, and treatment efficacy. Although we can evaluate tumor elasticity globally, it is more difficult to measure local rigidity deep down and to see whether the core of the tumor resists the penetration of therapeutic liquids. To probe these physical properties, the researchers have used a noncontact imaging technique that does not require the use of contrast agents – therefore that does not disturb tissue function – that exploits natural infinitesimal vibrations of matter.
To recapitulate the behavior of colorectal tumors in vitro, the researchers created organoids, spheres with diameter 0.3 mm formed by the aggregation of tumor cells. They focused a red laser beam onto these objects. The infinitesimal vibrations of the sample, generated by thermal agitation, modify very slightly the color of the light beam that exits the sample. By analyzing this light, a map of the mechanical properties of the model tumors is created: the more rigid the area scanned by the laser, the faster the vibrations and, in a manner comparable to the Doppler effect (the mechanism that makes a siren sound increasingly shrill as it gets closer), the greater the color change.
From organoids composed of two cell lines with different malignancies, the researchers have shown that they could distinguish the two cell types from their mechanical properties. Such information is crucial because it may allow diagnosis from biopsy analysis to be refined and offer better assessment of tumor grade. Local variations in mechanical properties after a drug treatment have also been monitored using this technique: the center of the tumor remains rigid longer than the edge, demonstrating the treatment’s efficacy gradient. So local measurement of mechanical properties could confirm the total destruction of the tumor and help in choosing as low a treatment dose and duration as possible.
This approach allows exploring the impact of mechanical properties on the therapeutic response. It should lead to more predictive in vitro tumor models for testing new therapeutic molecules and for combined therapies, which act for example on tissue rigidity to accelerate the penetration of active molecules in the center of the tumor. It could also provide new indicators to guide clinicians in personalization of therapies.
Learn more: Physics can show us the inside of tumors
The Latest on: Personalized cancer treatment
via Google News
The Latest on: Personalized cancer treatment
- More evidence that cellular 'death by iron' could be promising avenue of cancer treatmenton December 1, 2020 at 1:39 pm
Genetic mutations that give cancers a metabolic boost may also leave them vulnerable to drugs that promote a particular form of cell death, Sloan Kettering Institute researchers have found.
- For people with certain BRCA mutations, activating the immune system could be promising treatmenton December 1, 2020 at 11:12 am
Tumors with mutations in the cancer-predisposition gene respond better to checkpoint blockade immunotherapy than tumors with mutations in , scientists at Memorial Sloan Kettering have found.
- Computing empowers immune cells to kill canceron December 1, 2020 at 5:24 am
One of the most promising new cancer therapies involves engineering cells from the body's own immune system to attack tumors, but tuning those attackers to spare healthy tissues has been challenging.
- Project Outrun is asking for your shoes... to give custom kicks to kids with canceron November 30, 2020 at 10:58 pm
The Iowa chapter of Project Outrun will be collecting new and used shoes through the end of January. BETTENDORF, Iowa — When it comes to a new pair of shoes, it might be hard to think of a pair more ...
- New Publication from I-SPY 2 Trial Highlights Signatera's Ability to Predict Treatment Outcomes in Neoadjuvant Breast Cancer Patientson November 30, 2020 at 5:03 am
PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced a new paper published in Annals of ...
- A Perfect Match: Molecular Tests Developed at MSK Guide Personalized Treatment for Lung Canceron November 25, 2020 at 1:23 pm
For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.
- New nanotechology design provides hope for personalized ‘vaccination’ to treat canceron November 23, 2020 at 11:03 am
Published in Science Advances, a new study by University of Chicago scientists demonstrates a new approach that delivers a one-two punch against cancer cells: using tiny metal-organic frameworks to ...
- Persephone Biosciences Initiates the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Responseon November 23, 2020 at 6:33 am
Persephone Biosciences Inc., a biotechnology company that leverages real world data and artificial intelligence to design microbiome therapeutics and diagnostics to promote normal immune function and ...
- OneOncology Partners with Genentech to Bring Personalized Cancer Research to Patients at Community Oncology Siteson November 23, 2020 at 2:15 am
OneOncology, the national partnership of independent oncology practices, and Genentech, a member of the Roche Group (SIX: RO, ROG; ...
- University of Arizona clinical trial expanding after early results with personalized cancer vaccineon November 20, 2020 at 9:26 pm
It’s a treatment tailored specifically to the patient. Their cancer cells are used to develop a personalized vaccine that teaches their immune system how to recognize and destroy their cancer.
via Bing News